This breakthrough electronic nose was able to identify the presence of cancer cells with an accuracy of 92 percent.
By Luke Vorstermans
While the Sense of Smell Lab has put its focus on developing products such as the innovative aromapod, research into the power of this sense is gaining prominence in many facilities and universities across the globe.
New research by a team of Israeli scientists, who have been working with olfaction and a cure for cancer, believe they are a step closer to diagnosing this disease at an early stage.
The majority cancer patients who survive for a year or more are those who discover the presence of cancerous tissue early on. They usually respond well to treatment and live to tell their journey.
Some forms of cancer evade detection even when the proper scanning methods are used and come to light when it’s often too late to save the patient’s life. For people who have lost a loved one to cancer, the question often asked is – why wasn’t this detected earlier, in time to save his or her life?
The new olfactory device is modeled on the olfactory system of the dog and is capable of detecting cancer in the early stages by sniffing the breath of patients. Cancer tumors emanate molecules that circulate through our blood to the lungs and leave the body when we exhale. The electronic nose is capable of detecting the presence of this molecule and therefore able to detect the presence of cancerous tissue in the early stage of development.
The results of the clinical trials, carried out on 100 patients, some whom had cancer and others who didn’t, showed that the electronic olfactory device was able to identify the presence of cancer cells and to pinpoint the location and nature of the tumor with an accuracy of 92 percent.
Spokesman for the team said that while the research is in its early stages, the news comes as a ray of hope for the millions of people who live in dread of succumbing to the disease. The test is also a breakthrough, since it is non invasive and it takes very little time as opposed to a scan or fluid test.
This news is a welcome to the research for a cancer sure and gives more credence to the power of our olfactory system to detect disease.


Author's Bio: 

Luke Vorstermans is the Founder and CEO of The Sense of Smell Lab, a world leader in pioneering products that use the sense of smell for health, wellness and sheer smelling pleasure. The SOS Lab developed the Sniff n Go aromapod, the Scentuelle libido patch and Scent Therapy product line.